{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:53:46Z","timestamp":1791305626296,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","award":["Funding for this study was provided by a research grant from Grifols Pharmaceuticals (Barcelona"],"award-info":[{"award-number":["Funding for this study was provided by a research grant from Grifols Pharmaceuticals (Barcelona"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","award":["Spain). This was an investigator-initiated study (Drs Jackso"],"award-info":[{"award-number":["Spain). This was an investigator-initiated study (Drs Jackso"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","award":["Suarez co-PIs). The funder had no role in the design"],"award-info":[{"award-number":["Suarez co-PIs). The funder had no role in the design"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","award":["execution"],"award-info":[{"award-number":["execution"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","award":["data analysis of the study."],"award-info":[{"award-number":["data analysis of the study."]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12028-026-02491-6","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:42:54Z","timestamp":1775162574000},"page":"571-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combination of Albumin and Cilostazol Improves Outcomes in a Rodent Model of Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"45","author":[{"given":"A. Karim","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Feghali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chien","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Yazigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Khalifeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Chandan Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Fernando","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael J.","family":"Tamargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose I.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5958-2004","authenticated-orcid":false,"given":"Christopher M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2491_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamaneurol.2019.0006","volume":"76","author":"N Etminan","year":"2019","unstructured":"Etminan N, Chang HS, Hackenberg K, de Rooij NK, Vergouwen MDI, Rinkel GJE, et\u00a0al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis. JAMA Neurol. 2019;76:588\u201397.","journal-title":"JAMA Neurol"},{"key":"2491_CR2","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et\u00a0al. On behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics\u20142023 update: a report from the American Heart Association [published correction appears in Circulation. 2023;147:e622]. Circulation. 2023;147:e93\u2013621.","journal-title":"Circulation"},{"issue":"7","key":"2491_CR3","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, et\u00a0al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2023;54(7):e314\u201370. https:\/\/doi.org\/10.1161\/STR.0000000000000436.","journal-title":"Stroke"},{"key":"2491_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s12028-021-01372-4","volume":"36","author":"AI Qureshi","year":"2022","unstructured":"Qureshi AI, Lobanova I, Huang W, et\u00a0al. Lessons learned from phase II and phase III trials investigating therapeutic agents for cerebral ischemia associated with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2022;36:662\u201381.","journal-title":"Neurocrit Care"},{"key":"2491_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMra052732","volume":"354","author":"JI Suarez","year":"2006","unstructured":"Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387\u201396.","journal-title":"N Engl J Med"},{"key":"2491_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/S0140-6736(22)00938-2","volume":"400","author":"J Claassen","year":"2022","unstructured":"Claassen J, Park S. Spontaneous subarachnoid haemorrhage. Lancet. 2022;400:846\u201362.","journal-title":"Lancet"},{"key":"2491_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","volume":"10","author":"RL Macdonald","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et\u00a0al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10:618\u201325.","journal-title":"Lancet Neurol"},{"issue":"3","key":"2491_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000277","volume":"2007","author":"SM Dorhout Mees","year":"2007","unstructured":"Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, et\u00a0al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(3):CD000277. https:\/\/doi.org\/10.1002\/14651858.CD000277.","journal-title":"Cochrane Database Syst Rev"},{"key":"2491_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/cc10017","volume":"15","author":"GK Wong","year":"2011","unstructured":"Wong GK, Boet R, Poon WS, Chan MT, Gin T, Ng SC, et\u00a0al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care. 2011;15:R52. https:\/\/doi.org\/10.1186\/cc10017.","journal-title":"Crit Care"},{"key":"2491_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-022-01637-6","author":"AI Qureshi","year":"2022","unstructured":"Qureshi AI, Akhtar IN, Ma X, Lodhi A, Bhatti I, Beall J, et\u00a0al. Effect of Cilostazol in animal models of cerebral ischemia and subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2022. https:\/\/doi.org\/10.1007\/s12028-022-01637-6.","journal-title":"Neurocrit Care"},{"key":"2491_CR11","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1097\/CCM.0000000000001193","volume":"43","author":"Y Xie","year":"2015","unstructured":"Xie Y, Liu W, Zhang X, Wang L, Xu L, Xiong Y, et\u00a0al. Human albumin improves long-term behavioral sequelae after subarachnoid hemorrhage through neurovascular remodeling. Crit Care Med. 2015;43:e440\u20139.","journal-title":"Crit Care Med"},{"key":"2491_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/STROKEAHA.111.633958","volume":"43","author":"JI Suarez","year":"2012","unstructured":"Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, et\u00a0al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43:683\u201390.","journal-title":"Stroke"},{"key":"2491_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-3-319-04981-6_48","volume":"120","author":"JI Suarez","year":"2015","unstructured":"Suarez JI, Martin RH, Calvillo E, Bershad EM, Venkatasubba Rao CP. Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study. Acta Neurochir Suppl. 2015;120:287\u201390.","journal-title":"Acta Neurochir Suppl"},{"issue":"5","key":"2491_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1179\/016164102101200276","volume":"24","author":"A Parra","year":"2002","unstructured":"Parra A, McGirt MJ, Sheng H, Laskowitz DT, Pearlstein RD, Warner DS. Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res. 2002;24(5):510\u20136. https:\/\/doi.org\/10.1179\/016164102101200276. (PMID: 12117325.).","journal-title":"Neurol Res"},{"key":"2491_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jneumeth.2011.01.010","volume":"196","author":"A Encarnacion","year":"2011","unstructured":"Encarnacion A, Horie N, Keren-Gill H, Bliss TM, Steinberg GK, Shamloo M. Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods. 2011;196:247\u201357.","journal-title":"J Neurosci Methods"},{"key":"2491_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093121","volume":"9","author":"A Madinier","year":"2014","unstructured":"Madinier A, Quattromani MJ, Sj\u00f6lund C, Ruscher K, Wieloch T. Enriched housing enhances recovery of limb placement ability and reduces aggrecan-containing perineuronal nets in the rat somatosensory cortex after experimental stroke. PLoS ONE. 2014;9:e93121.","journal-title":"PLoS ONE"},{"key":"2491_CR17","first-page":"73","volume":"22","author":"PM Lenzlinger","year":"2004","unstructured":"Lenzlinger PM, Saatman KE, Hoover RC, Cheney JA, Bareyre FM, Raghupathi R, et\u00a0al. Inhibition of vascular endothelial growth factor receptor (VEGFR) signaling by BSF476921 attenuates regional cerebral edema following traumatic brain injury in rats. Restor Neurol Neurosci. 2004;22:73\u20139.","journal-title":"Restor Neurol Neurosci"},{"key":"2491_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/STROKEAHA.110.597344","volume":"42","author":"Y Hasegawa","year":"2011","unstructured":"Hasegawa Y, Suzuki H, Altay O, Zhang JH. Preservation of tropomyosin-related kinase B (TrkB) signaling by sodium orthovanadate attenuates early brain injury after subarachnoid hemorrhage in rats. Stroke. 2011;42:477\u201383.","journal-title":"Stroke"},{"key":"2491_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-319-18497-5_15","volume":"121","author":"Y Hasegawa","year":"2016","unstructured":"Hasegawa Y, Suzuki H, Nakagawa T, Uekawa K, Koibuchi N, Kawano T, et\u00a0al. Assessment of the correlations between brain weight and brain edema in experimental subarachnoid hemorrhage. Acta Neurochir Suppl. 2016;121:89\u201392.","journal-title":"Acta Neurochir Suppl"},{"key":"2491_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbi.2023.12.007","volume":"116","author":"JE Kim","year":"2024","unstructured":"Kim JE, Lee RP, Yazigi E, Atta L, Feghali J, Pant A, et\u00a0al. Soluble PD-L1 reprograms blood monocytes to prevent cerebral edema and facilitate recovery after ischemic stroke. Brain Behav Immun. 2024;116:160\u201374. https:\/\/doi.org\/10.1016\/j.bbi.2023.12.007. (Epub 2023 Dec 7. PMID: 38070624; PMCID: PMC11220828.).","journal-title":"Brain Behav Immun"},{"key":"2491_CR21","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.neuroimage.2011.12.055","volume":"60","author":"F Kara","year":"2012","unstructured":"Kara F, Dongen ES, Schliebs R, Buchem MA, Groot HJ, Alia A. Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer\u2019s disease by in vivo magnetic resonance angiography at 17.6 T. Neuroimage. 2012;60:958\u201366.","journal-title":"Neuroimage"},{"issue":"2","key":"2491_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227349","volume":"15","author":"D Mielke","year":"2020","unstructured":"Mielke D, Bleuel K, Stadelmann C, Rohde V, Malinova V. The ESAS-score: a histological severity grading system of subarachnoid hemorrhage using the modified double hemorrhage model in rats. PLoS ONE. 2020;15(2):e0227349. https:\/\/doi.org\/10.1371\/journal.pone.0227349. (PMID: 32097426; PMCID: PMC7041796.).","journal-title":"PLoS ONE"},{"key":"2491_CR23","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.12659\/msm.896499","volume":"22","author":"T Mutoh","year":"2016","unstructured":"Mutoh T, Mutoh T, Sasaki K, Nakamura K, Taki Y, Ishikawa T. Value of three-dimensional maximum intensity projection display to assist in magnetic resonance imaging (MRI)-Based grading in a mouse model of subarachnoid hemorrhage. Med Sci Monit. 2016;22:2050\u20135. https:\/\/doi.org\/10.12659\/msm.896499. (PMID: 27307024; PMCID: PMC4913823.).","journal-title":"Med Sci Monit"},{"issue":"9","key":"2491_CR24","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","volume":"32","author":"J Claassen","year":"2001","unstructured":"Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, et\u00a0al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32(9):2012\u201320. https:\/\/doi.org\/10.1161\/hs0901.095677. (PMID: 11546890.).","journal-title":"Stroke"},{"key":"2491_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","volume":"389","author":"RL Macdonald","year":"2017","unstructured":"Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389:655\u201366.","journal-title":"Lancet"},{"key":"2491_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1227\/01.NEU.0000359317.15269.20","volume":"65","author":"MV Springer","year":"2009","unstructured":"Springer MV, Schmidt JM, Wartenberg KE, Frontera JA, Badjatia N, Mayer SA. Predictors of global cognitive impairment 1 year after subarachnoid hemorrhage. Neurosurgery. 2009;65:1043\u201351.","journal-title":"Neurosurgery"},{"key":"2491_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S1474-4422(09)70126-7","volume":"8","author":"DJ Nieuwkamp","year":"2009","unstructured":"Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635\u201342.","journal-title":"Lancet Neurol"},{"key":"2491_CR28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.410140602","volume":"14","author":"RC Heros","year":"1983","unstructured":"Heros RC, Zervas NT, Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol. 1983;14:599\u2013608.","journal-title":"Ann Neurol"},{"key":"2491_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/STROKEAHA.112.674291","volume":"44","author":"NK de Rooij","year":"2013","unstructured":"de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ. Delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review of clinical, laboratory, and radiological predictors. Stroke. 2013;44:43\u201354.","journal-title":"Stroke"},{"key":"2491_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/jnnp.68.3.337","volume":"68","author":"YB Roos","year":"2000","unstructured":"Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry. 2000;68:337\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2491_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12028-023-01747-9","volume":"39","author":"VA Shah","year":"2023","unstructured":"Shah VA, Gonzalez LF, Suarez JI. Therapies for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39:36\u201350. https:\/\/doi.org\/10.1007\/s12028-023-01747-9.","journal-title":"Neurocrit Care"},{"issue":"6","key":"2491_CR32","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1161\/STROKEAHA.121.035699","volume":"53","author":"M Dayyani","year":"2022","unstructured":"Dayyani M, Sadeghirad B, Grotta JC, Zabihyan S, Ahmadvand S, Wang Y, et\u00a0al. Prophylactic therapies for morbidity and mortality after aneurysmal subarachnoid hemorrhage: a systematic review and network meta-analysis of randomized trials. Stroke. 2022;53(6):1993\u20132005. https:\/\/doi.org\/10.1161\/STROKEAHA.121.035699. (Epub 2022 Mar 31 PMID: 35354302).","journal-title":"Stroke"},{"key":"2491_CR33","first-page":"33","volume":"10","author":"AI Qureshi","year":"2018","unstructured":"Qureshi AI, Ishfaq A, Ishfaq MF, Pandhi A, Ahmed SI, Singh S, et\u00a0al. Therapeutic benefit of Cilostazol in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized and nonrandomized studies. J Vasc Interv Neurol. 2018;10:33\u201340.","journal-title":"J Vasc Interv Neurol"},{"issue":"11","key":"2491_CR34","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.027","volume":"27","author":"H Saber","year":"2018","unstructured":"Saber H, Desai A, Palla M, Mohamed W, Seraji-Bozorgzad N, Ibrahim M. Efficacy of cilostazol in prevention of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a meta-analysis. J Stroke Cerebrovasc Dis. 2018;27(11):2979\u201385. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.06.027. (Epub 2018 Aug 6 PMID: 30093204).","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"2","key":"2491_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000518731","volume":"51","author":"J Liu","year":"2022","unstructured":"Liu J, He J, Chen X, Feng Y, Wang C, Awil MA, et\u00a0al. Cilostazol for aneurysmal subarachnoid hemorrhage: an updated systematic review and meta-analysis. Cerebrovasc Dis. 2022;51(2):138\u201348. https:\/\/doi.org\/10.1159\/000518731.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"2491_CR36","first-page":"33","volume":"10","author":"AI Qureshi","year":"2018","unstructured":"Qureshi AI, Ishfaq A, Ishfaq MF, Pandhi A, Ahmed SI, Singh S, et\u00a0al. Therapeutic benefit of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized and nonrandomized studies. J Vasc Interv Neurol. 2018;10(2):33\u201340 (PMID: 30746008; PMCID: PMC6350875.).","journal-title":"J Vasc Interv Neurol"},{"key":"2491_CR37","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208187","author":"A Qureshi","year":"2024","unstructured":"Qureshi A, Muraoka S, Saito R, Lodhi A, Maqsood H, Beall J, et\u00a0al. Cilostazol treatment and serum albumin concentration in patients with aneurysmal subarachnoid hemorrhage (P8-5.017). Neurology. 2024. https:\/\/doi.org\/10.1212\/WNL.0000000000208187.","journal-title":"Neurology"},{"key":"2491_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuroscience.2016.12.033","volume":"344","author":"L Wang","year":"2017","unstructured":"Wang L, Li M, Xie Y, Xu L, Ye R, Liu X. Preclinical efficacy of human albumin in subarachnoid hemorrhage. Neuroscience. 2017;344:255\u201364. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.12.033.","journal-title":"Neuroscience"},{"issue":"3","key":"2491_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1161\/STROKEAHA.111.633958","volume":"43","author":"JI Suarez","year":"2012","unstructured":"Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, et\u00a0al. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke. 2012;43(3):683\u201390. https:\/\/doi.org\/10.1161\/STROKEAHA.111.633958. (Epub 2012 Jan 19. PMID: 22267829; PMCID: PMC3288646.).","journal-title":"Stroke"},{"issue":"1","key":"2491_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10143-024-02543-5","volume":"47","author":"S Luzzi","year":"2024","unstructured":"Luzzi S, Bekta\u015fo\u011flu PK, Do\u011fruel Y, G\u00fcngor A. Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia. Neurosurg Rev. 2024;47(1):305. https:\/\/doi.org\/10.1007\/s10143-024-02543-5.","journal-title":"Neurosurg Rev"},{"issue":"10","key":"2491_CR41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71566","volume":"16","author":"NK Bains","year":"2024","unstructured":"Bains NK, Ngo M, Bhatti IA, Gomez FE, Arora NA, Chandrasekaran PN, et\u00a0al. Enteral cilostazol and high-dose intravenous albumin in aneurysmal subarachnoid hemorrhage patients with refractory cerebral ischemia. Cureus. 2024;16(10):e71566. https:\/\/doi.org\/10.7759\/cureus.71566.","journal-title":"Cureus"},{"issue":"3","key":"2491_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12028-022-01637-6","volume":"38","author":"AI Qureshi","year":"2023","unstructured":"Qureshi AI, Akhtar IN, Ma X, Lodhi A, Bhatti I, Beall J, et\u00a0al. Effect of cilostazol in animal models of cerebral ischemia and subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2023;38(3):698\u2013713. https:\/\/doi.org\/10.1007\/s12028-022-01637-6.","journal-title":"Neurocrit Care"},{"issue":"1","key":"2491_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03016-5","volume":"15","author":"C Xiang","year":"2025","unstructured":"Xiang C, Liu F, Liu B, Guo W, Wu H, Hou F, et\u00a0al. Optimization and evaluation of an experimental subarachnoid hemorrhage model in mice. Sci Rep. 2025;15(1):18285. https:\/\/doi.org\/10.1038\/s41598-025-03016-5.","journal-title":"Sci Rep"},{"issue":"9","key":"2491_CR44","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/01.str.0000027207.67639.1e","volume":"33","author":"MJ McGirt","year":"2002","unstructured":"McGirt MJ, Parra A, Sheng H, Higuchi Y, Oury TD, Laskowitz DT, et\u00a0al. Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke. 2002;33(9):2317\u201323. https:\/\/doi.org\/10.1161\/01.str.0000027207.67639.1e.","journal-title":"Stroke"},{"issue":"8","key":"2491_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011699","volume":"8","author":"K Matsumura","year":"2019","unstructured":"Matsumura K, Kumar TP, Guddanti T, Yan Y, Blackburn SL, McBride DW. Neurobehavioral deficits after subarachnoid hemorrhage in mice: sensitivity analysis and development of a new composite score. J Am Heart Assoc. 2019;8(8):e011699. https:\/\/doi.org\/10.1161\/JAHA.118.011699.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2491_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.expneurol.2011.10.029","volume":"233","author":"JM Pisapia","year":"2012","unstructured":"Pisapia JM, Xu X, Kelly J, Yeung J, Carrion G, Tong H, et\u00a0al. Microthrombosis after experimental subarachnoid hemorrhage: time course and effect of red blood cell-bound thrombin-activated pro-urokinase and Clazosentan. Exp Neurol. 2012;233(1):357\u201363. https:\/\/doi.org\/10.1016\/j.expneurol.2011.10.029. (Epub 2011 Nov 4. PMID: 22079156; PMCID: PMC5505050.).","journal-title":"Exp Neurol"},{"issue":"12","key":"2491_CR47","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1161\/01.str.30.12.2752","volume":"30","author":"Stroke Therapy Academic Industry Roundtable (STAIR)","year":"1999","unstructured":"Stroke Therapy Academic Industry Roundtable (STAIR). Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752\u20138. https:\/\/doi.org\/10.1161\/01.str.30.12.2752. (PMID: 10583007.).","journal-title":"Stroke"},{"issue":"11","key":"2491_CR48","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1177\/0271678X19887052","volume":"40","author":"V Weyer","year":"2020","unstructured":"Weyer V, Maros ME, Kronfeld A, Kirschner S, Groden C, Sommer C, et\u00a0al. Longitudinal imaging and evaluation of SAH-associated cerebral large artery vasospasm in mice using micro-CT and angiography. J Cereb Blood Flow Metab. 2020;40(11):2265\u201377. https:\/\/doi.org\/10.1177\/0271678X19887052. (Epub 2019 Nov 21. PMID: 31752586; PMCID: PMC7585924.).","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2491_CR49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/01.str.32.2.553","volume":"32","author":"L Belayev","year":"2001","unstructured":"Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke. 2001;32(2):553\u201360. https:\/\/doi.org\/10.1161\/01.str.32.2.553.","journal-title":"Stroke"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02491-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-026-02491-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-026-02491-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:10:51Z","timestamp":1791303051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-026-02491-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2491"],"URL":"https:\/\/doi.org\/10.1007\/s12028-026-02491-6","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Suarez received consulting fee from AstraZeneca (<\u2009$5000), compensations for membership on Advisory Committee (DSMB) for Acasti and Perfuze (<\u2009$10,000), and noncompensated role as advisor for Cyban. Dr. Jackson is a cofounder of Egret Therapeutics with equity interests in the company. He has received research support from Biohaven and InCephalo. Dr. Jackson and Dr. Suarez received a grant from Grifols to support this work. Dr. Jackson and Dr. Suarez were responsible for the planning, execution, and oversight of this study. CMJ received additional research support from the Florence D. and Irving J. Sherman MD Charitable Foundation Trust.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study did not involve human subjects.","order":2,"name":"Ethics","label":"Ethical approval\/informed consent","group":{"name":"EthicsHeading","label":"Ethics"}}]}}